Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001479290-21-000093)

Filing Details

Accession Number:: 0001479290-21-000093
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-04-06 19:41:39
Reporting Period:: 2021-04-05

Accepted Time:: 2021-04-06 19:41:39
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1479290	Revance Therapeutics Inc.	RVNC	Pharmaceutical Preparations (2834)	770551645

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1818576	Aubrey Rankin	C/O Revance Therapeutics, Inc 1222 Demonbreun Street, Suite 1001 Nashville TN 37203	President, Innovation & Tech	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-04-05	2	$28.28	411,325	No	4	S	Indirect	Aubrey and Luanne Rankin Revocable Living Trust Dated July 1, 2009

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Aubrey and Luanne Rankin Revocable Living Trust Dated July 1, 2009

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	174,302	Indirect	The Rankin Irrevocable Trust
Common Stock	79,776	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by Mr. Rankin.
These shares are held by the Aubrey and Luanne Rankin Revocable Living Trust dated July 1, 2009. Mr. Rankin is a Trustee of this Trust.
These shares are held by The Rankin Irrevocable Trust. Mr. Rankin is a Trustee of the Rankin Irrevocable Trust.